Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd of the Company for the Quarter ended 31deg March, 2020. Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and 'Code of Conduct for prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the Trading Window for dealing in securities of the Company will remain closed from 1" April, 2020 till 48 hours after declaration of the Audited Financial Results of the Company for the quarter and financial year ended 31' March, 2020 for the designated persons. Accordingly, all the Designated Persons of the Company have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended March 31, 2020
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here Fredun Pharmaceuticals Ltd - 539730 - Clarification sought from Fredun Pharmaceuticals Ltd
The Exchange has sought clarification from Fredun Pharmaceuticals Ltd on April 16th , 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of the Financial Statements for Quarter and Nine months ended December 31, 2019 In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Nine months ended December 31, 2019; as approved by the Board in its Meeting held on Wednesday, February 12, 2020; published in Business Standard & Mumbai Lakshadeep newspaper(s) on Friday, February 14, 2020. Fredun Pharmaceuticals Ltd - 539730 - Subject: Approved Unaudited Financial Results For Quarter And Nine Months Ended December 31, 2019
In compliance to Regulation 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Wednesday, February 12, 2020; had considered and approved the Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2019; along with the Limited Review Report issued by M/s. Savla & Associates, Statutory Auditors of the Company; the copies of which are attached hereunder. Any other matter: 1. Approval of Appointment of Ms. Ankita Joshi (ACS43193) as Company Secretary cum Compliance Officer in compliance to the provisions of Section 203 of the Companies Act, 2013 and Rules made thereunder and Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (Annexure 1) Fredun Pharmaceuticals Ltd - 539730 - Update on board meeting
The Board Meeting to be held on 12/02/2020 has been revised to 12/02/2020 In compliance to Regulation 47 of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Wednesday, February 12, 2020 at 3:30 P.M.; published in Business Standard & Mumbai Lakshadeep newspapers on February 1, 2020. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015; Ms. Priyanka Arun Chaturvedi, Company Secretary Cum Compliance Officer of the Company has resigned from the post w.e.f. January 31, 2020 due to pre-occupancy. Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Intimation Of The 176Th Board Meeting
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the 176th Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 12, 2020 at 3:30 P.M. at the Registered Office of the Company interalia to discuss, consider and approve the Unaudited Financial Results of the Company for the Quarter and nine months ended December 31, 2019.